Compliance and Toxicity of Total Neoadjuvant Therapy for Rectal Cancer: A Secondary Analysis of the OPRA Trial.
Verheij FS, Omer DM, Lin ST, Yuval JB, Thompson HM, Kim JK, Valdivieso SC, Qin LX, Wu AJ, Saltz LB, Garcia-Aguilar J.
Verheij FS, et al. Among authors: valdivieso sc.
Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):115-123. doi: 10.1016/j.ijrobp.2023.07.043. Epub 2023 Aug 5.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 37544412
Clinical Trial.